July 23, 2024 7:40 am

The premier news source for Snohomish County

FDA-authorized Paxlovid by Pfizer offers no benefit to non-seniors


A study of over 100 thousand patients published in the New England Journal of Medicine on August 24, 2022, shows that oral protease inhibitor nirmatrelvir, used in combination with ritonavir under the brand name Paxlovid, offered no evidence of statistically reducing the rate of hospitalization from COVID among both treated and untreated patients 40 to […]

Join Our Mailing List

Verified by MonsterInsights